| Value | ₹0.01 Cr |
|---|
NSE filing, NSE: DAVANGERE. Summary written from the filing by ALFA Finder's alert engine.
Davangere Sugar Company Ltd: key numbers
- Share price
- ₹1.99
- Market cap
- ₹284.6 Cr
- Revenue (annual)
- ₹238.8 Cr
- Net profit (annual)
- ₹8.51 Cr
- P/E (TTM)
- 35.0×Sector 26.2×
- Promoter holding
- 41.63%+0.00% QoQ
- FII holding
- 0.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Davangere Sugar Company Ltd
All →Davangere Sugar Company Convertible Warrants
Davangere Sugar received BSE and NSE in-principle approval to issue 10,64,11,079 convertible warrants to promoters. The warrants are priced at Rs.3.77 each, about Rs.40.12 Crore.
- Value
- ₹40.12 Cr
Davangere Sugar Company Other Announcement
Davangere Sugar Company Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Davangere Sugar Company Annual General Meeting
Davangere Sugar issued a corrigendum to its 55th AGM notice, clarifying the consideration for the preferential issue of warrants to promoters is discharged via loan conversion.
Davangere Sugar Company Annual General Meeting
Davangere Sugar Company Limited filed the Scrutinizer's report for its 55th Annual General Meeting held on September 12, 2026, detailing the final voting results.
Davangere Sugar Company Annual General Meeting
Davangere Sugar issued a corrigendum to its 55th AGM notice. It provides web links to valuation reports and confirms the warrant issue price of ₹3.77.
Davangere Sugar Company Capital Structure Change
Davangere Sugar Company allotted 26.59 crore equity shares following the conversion of 100 FCCBs. This issuance significantly alters the company's capital structure.
- Value
- ₹95.00 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr